While international actors discuss governance and reconstruction, Netanyahu has made it clear that Israel has no intention of ending its military occupation, says RAMZY BAROUD
Latest editorial
Patents: how the profit machine costs lives
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, California; (insert) Descovy used for HIV prevention through pre-exposure prophylaxis
[(L to R) Coolcaesar/CC - EEJCC/CC]
NICK WRIGHT continues his series analysing the trends in European politics
We have the alternative economics, histories of our struggles and the confidence to change the world
General Federation of Trade Unions assistant general secretary HENRY FOWLER reports on the final day from the GFTU’s residential Summer School at the Workers’ Retreat, Quorn Grange Hotel
Capitalism has exploited — and polluted — our natural resources for too long, it’s time we treated our rivers as living beings, writes MIRIUM GAUNTLETT, LIAM SHAW and ROX MIDDLETON
Treating the Clacton by-election as a joke risks reinforcing the Reform leader’s claim to be the victim of an out-of-touch Establishment, argues JOHN McINALLY
MPs and others called for the urgent release of tortured Palestinian doctor, Hussam Abu Safiya, held hostage by Israel and reportedly near death, reports LINDA PENTZ GUNTER
DECIDING a particular year when a scientific discovery or advance took place is often an arbitrary decision. Archimedes is said to have leapt from his bathtub and shouted “Eureka!” when he realised that the volume of any object, no matter how complicated, could be found by placing the object in water and measuring the volume of water it displaces.
But even that eureka moment is of dubious authenticity. It is rare for scientific research to advance in a glorious instant of revelation.
So when the journal Science named the HIV/AIDS drug lenacapavir as its “breakthrough of the year,” it shouldn’t be surprising that its story began far earlier.
Similar stories
CLAUDIA WEBBE says the horrific price British patients will pay for this NHS deal is now clear — and there’s time to get out of it, if MPs will only force the issue
1943-2025: How one man’s unfinished work reveals the lethal lie of ‘colour-blind’ medicine
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS